Cellular Markers in Treated or Untreated Non-tuberculous Mycobacterial Respiratory Infection in Patients With Cystic Fibrosis

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Montpellier

About this trial

This study evaluates a diagnostic serological test for Non-Tuberculous Mycobacteria (NTM) infection in cystic fibrosis patients by measuring T cell response. It aims to highlight a dynamic response associated to the pathogen's presence. This multicenter case-control study involves two populations, providing a better understanding of the circulating T-IFNγ-MNT response in these patients.

Eligibility criteria

Qualifiers

Patient ≥18 years

Patient previously included in the CIMeNT study

Patient with a confirmed diagnosis of cystic fibrosis regardless of CFTR genotype

Patient affiliated to the social security system

Disqualifiers

Lung transplant patients

Person placed under judicial protection

Pregnant and breastfeeding women

Trial design

Treatments tested in this trial

  • Scheduled visit (V1)

Treatment groups

76 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University Hospital, Montpellier

Lead sponsor

Hôpital Cochin

Collaborator

Cystic Fibrosis Foundation

Collaborator